Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03485924 · ClinicalTrials.gov registry record · NA
EUS FNB Versus FNA With On-Site Cytopathology in Solid Pancreatic Masses
A NA study, sponsored by Johns Hopkins University.
- Terminated
- Registry status
- NA
- Development phase
- 40
- Enrollment target
NCT03485924: Clinical Trial NA study, sponsored by Johns Hopkins University.
NCT03485924 is a NA study that was terminated before completion, run by Johns Hopkins University. The registered enrollment target is 40 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03485924, a NA study, was terminated before completion, sponsored by Johns Hopkins University.
- TERMINATED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
Study Summary
The objective of this paired cohort study is to evaluate the diagnostic accuracy of Endoscopic Ultrasound-fine needle aspiration (EUS-FNA) with rapid onsite evaluation (ROSE) compared to EUS-fine needle biopsy (EUS-FNB) without ROSE. If EUS-FNB without ROSE is shown to be non-inferior to the current standard of care of EUS-FNA with ROSE in pancreatic lesions, this study has the potential to make EUS-guided tissue acquisition more economical (with elimination for the need for cytopathology staff onsite) as well as provide core histological specimen without sacrificing the overall diagnostic yield.
Interventions
- DIAGNOSTIC_TEST EUS-FNA with ROSE
- DIAGNOSTIC_TEST EUS-FNB without ROSE
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2018-04-12 |
| Est. Completion | 2023-07-26 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03485924
The ClinicalTrials.gov registry entry for NCT03485924 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which EUS-FNA with ROSE is the first listed.
NCT03485924 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03485924 about?
NCT03485924 is a clinical study titled "EUS FNB Versus FNA With On-Site Cytopathology in Solid Pancreatic Masses". The objective of this paired cohort study is to evaluate the diagnostic accuracy of Endoscopic Ultrasound-fine needle aspiration (EUS-FNA) with rapid onsite evaluation (ROSE) compared to EUS-fine needle biopsy (EUS-FNB) without ROSE. If EUS-FNB without ROSE is shown to be non-inferior to the current...
What is the current status of trial NCT03485924?
This trial is currently terminated. It is a NA study. The enrollment target is 40 participants. The study started on 2018-04-12. Estimated completion is 2023-07-26.
What interventions are being tested in trial NCT03485924?
The interventions under investigation include: EUS-FNA with ROSE (DIAGNOSTIC_TEST), EUS-FNB without ROSE (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03485924?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.